Table 4.

Univariate analysis of variables related with graft loss in patients presenting with BKVAN.

				Univariate Analysis
	Category	n	Graft Loss n (%)	OR (95% CI)	p Value
Gender	Male	15	7 (47)	0.2 (0.01–1.6)	0.1
	Female	8	1 (3)
Age	Age ≥ 60	5	1 (20)	0.4 (0.03–4.2)	0.4
	Age < 60	18	7 (39)
Diabetes mellitus	Yes	10	6 (60)	8 (1.1–59)	0.04
	No	13	2 (15)
Hepatitis C virus infection	Yes	2	1 (50)	2 (0.1–37)	0.6
	No	21	7 (33)
Induction treatment	Yes	21	8 (38)	-
	No	2	0
Hemodialysis requirement	Yes	2	1 (50)	2 (0.1–37)	0.6
	No	21	7 (33)
Nephrostomy requirement	Yes	4	3 (75)	8.4 (0.7–100)	0.09
	No	19	5 (26)
CMV infection	Yes	9	7 (78)	45 (3.4–594)	0.004
	No	14	1 (7)
CMV disease	Yes	3	2 (67)	4.7 (0.3–62)	0.2
	No	20	6 (30)
CMV serology D+/R-	Yes	4	1 (25)	0.6 (0.05–6.6)	0.6
	No	19	7 (37)
Acute allograft rejection	Yes	11	5 (45)	2.5 (0.4–14.6)	0.3
	No	12	3 (25)
Receipt of >1 pulses of 1 g intravenous methylprednisolone		7	3	0.8 (0.5–1.6)	0.9
Timoglobulin		2	1
Receipt of rituximab		2	1